Kafi N. Sanders

857 total citations
17 papers, 641 citations indexed

About

Kafi N. Sanders is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kafi N. Sanders has authored 17 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Economics and Econometrics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kafi N. Sanders's work include Schizophrenia research and treatment (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Bipolar Disorder and Treatment (5 papers). Kafi N. Sanders is often cited by papers focused on Schizophrenia research and treatment (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Bipolar Disorder and Treatment (5 papers). Kafi N. Sanders collaborates with scholars based in United States. Kafi N. Sanders's co-authors include Kelly H. Zou, Carol S. Weisse, Paul Clay Sorum, Marko A. Mychaskiw, Brian J. Cuffel, José Alvir, James Harnett, Jack Mardekian, Xiaoqin Yang and Joseph Thomas and has published in prestigious journals such as CHEST Journal, Journal of General Internal Medicine and Schizophrenia Research.

In The Last Decade

Kafi N. Sanders

16 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kafi N. Sanders United States 10 203 96 79 79 75 17 641
Josep Darbà Spain 16 160 0.8× 101 1.1× 140 1.8× 191 2.4× 78 1.0× 109 906
Patrizia Berto Italy 20 172 0.8× 63 0.7× 93 1.2× 146 1.8× 46 0.6× 74 1.1k
Julie Birt United States 22 214 1.1× 83 0.9× 46 0.6× 226 2.9× 82 1.1× 61 1.2k
Gerardo Machnicki United States 15 188 0.9× 83 0.9× 55 0.7× 93 1.2× 128 1.7× 42 790
Victor Heh United States 16 142 0.7× 67 0.7× 119 1.5× 33 0.4× 70 0.9× 42 768
Diana Rofail United States 16 195 1.0× 161 1.7× 40 0.5× 89 1.1× 87 1.2× 43 1.2k
Rachel Halpern United States 15 149 0.7× 52 0.5× 92 1.2× 96 1.2× 90 1.2× 42 822
Tim Crayford United Kingdom 14 286 1.4× 161 1.7× 102 1.3× 89 1.1× 108 1.4× 23 1.0k
Maureen C. O’Keeffe Rosetti United States 10 101 0.5× 88 0.9× 90 1.1× 106 1.3× 39 0.5× 18 828
Krista Payne United States 14 106 0.5× 53 0.6× 40 0.5× 85 1.1× 49 0.7× 21 893

Countries citing papers authored by Kafi N. Sanders

Since Specialization
Citations

This map shows the geographic impact of Kafi N. Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kafi N. Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kafi N. Sanders more than expected).

Fields of papers citing papers by Kafi N. Sanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kafi N. Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kafi N. Sanders. The network helps show where Kafi N. Sanders may publish in the future.

Co-authorship network of co-authors of Kafi N. Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of Kafi N. Sanders. A scholar is included among the top collaborators of Kafi N. Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kafi N. Sanders. Kafi N. Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Sanders, Kafi N., et al.. (2018). Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. Journal of Multidisciplinary Healthcare. Volume 11. 295–304. 170 indexed citations
3.
Yang, Xiaoqin, Kafi N. Sanders, Jack Mardekian, Marko A. Mychaskiw, & Joseph Thomas. (2015). Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease. Clinical Therapeutics. 37(5). 1055–1063. 3 indexed citations
4.
Yang, Xiaoqin, Jack Mardekian, Kafi N. Sanders, Marko A. Mychaskiw, & Joseph Thomas. (2013). Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature. Clinical Rheumatology. 32(10). 1519–1531. 56 indexed citations
5.
6.
Murawski, Matthew M., et al.. (2011). Establishing the Need for Development of a Patient Reported Outcome Instrument in Pulmonary Arterial Hypertension. CHEST Journal. 140(4). 711A–711A. 1 indexed citations
7.
Rascati, Karen L., Kristin M. Richards, Carol A. Ott, et al.. (2011). Adherence, Persistence of Use, and Costs Associated With Second-Generation Antipsychotics for Bipolar Disorder. Psychiatric Services. 62(9). 1032–1040. 29 indexed citations
8.
Crabtree, Brian L., et al.. (2011). Outcome Assessment of an Antipsychotic Drug Algorithm: Effects of the Mississippi State Hospital Algorithm Project. Psychiatric Services. 62(8). 963–965. 2 indexed citations
9.
Murawski, Matthew M., et al.. (2011). Fatigue in Pulmonary Arterial Hypertension: Defining and Measuring a Key Symptom for Instrument Development. CHEST Journal. 140(4). 710A–710A.
10.
Rascati, Karen L., Kristin M. Richards, Carol A. Ott, et al.. (2011). Adherence, Persistence of Use, and Costs Associated With Second-Generation Antipsychotics for Bipolar Disorder. Psychiatric Services. 62(9). 10 indexed citations
11.
Crabtree, Brian L., et al.. (2011). Outcome Assessment of an Antipsychotic Drug Algorithm: Effects of the Mississippi State Hospital Algorithm Project. Psychiatric Services. 62(8). 1 indexed citations
12.
Correll, Christoph U., Benjamin G. Druss, Ilise Lombardo, et al.. (2010). Findings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients. Psychiatric Services. 61(9). 892–898. 87 indexed citations
13.
Campbell, E. Cabrina, Barry K. Herman, Brian J. Cuffel, et al.. (2010). A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(1). 246–251. 3 indexed citations
14.
Citrome, Leslie, Christopher Reist, Liisa Palmer, et al.. (2009). Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder. Schizophrenia Research. 115(2-3). 115–120. 16 indexed citations
15.
Citrome, Leslie, Christopher Reist, Liisa Palmer, et al.. (2008). Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. Schizophrenia Research. 108(1-3). 238–244. 28 indexed citations
16.
Hess, Gregory P., Kafi N. Sanders, Jerrold Hill, & Larry Z. Liu. (2007). Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.. PubMed. 13 Suppl 3. S80–5. 23 indexed citations
17.
Weisse, Carol S., et al.. (2001). Do gender and race affect decisions about pain management?. Journal of General Internal Medicine. 16(4). 211–217. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep Darbà Breakdown of academic impact, for papers by Patrizia Berto Breakdown of academic impact, for papers by Julie Birt Breakdown of academic impact, for papers by Gerardo Machnicki Breakdown of academic impact, for papers by Victor Heh Breakdown of academic impact, for papers by Diana Rofail Breakdown of academic impact, for papers by Rachel Halpern Breakdown of academic impact, for papers by Tim Crayford Breakdown of academic impact, for papers by Maureen C. O’Keeffe Rosetti Breakdown of academic impact, for papers by Krista Payne
Rankless by CCL
2026